How product quality testing is performed is an important factor when considering a change to your IVF culture media system. Join our upcoming webinar "What should you consider when changing your IVF culture media system?" where Erik Strait, MEA Lab Manager at Vitrolife Group, will educate us on the extensive oil testing process and how assessments and acceptance criteria used in the Mouse Embryo Assay (MEA) are critical aspects of a sensitive assay. Additionally, Dr. George Koustas, Director of Embryology at Columbia Fertility Center, will share his experience with implementing the Vitrolife culture system to the laboratory, offering valuable insights on how to ensure a smooth transition. 📅 Date: October 15th ⏰ Time: 12:00 (PST) / 15:00 (EST) /21:00 (CEST) 👉 Register here: https://ow.ly/rSbJ50TBYw5 The Vitrolife MEA is the most valuable tool we have to ensure safe and consistent products. It makes it possible for clinics to create a safe and optimal environment for embryo development and ultimately ensure successful results for patients. Learn more here: https://ow.ly/Rf1G50TBYw6 #VitrolifeGroup #Vitrolife #Igenomix #IVF #VitrolifeAcademy #Qualityalltheway #FertilityTreatment #IVFclinic #IVFsuccess #Embryology
Om oss
The Vitrolife Group is a world-leading global provider of medical devices and genetic testing testing solutions. Dedicated to the reproductive-health market since 1994, we have grown by focusing on product development, groundbreaking research, consistent quality control and acquisitions of innovative companies in the industry. In 2021, Vitrolife acquired Igenomix, a leader in reproductive genetic testing services primarily for IVF clinics. Together we are now the Vitrolife Group, a global leader in reproductive health focused on supporting our customers and patients worldwide to improve treatment outcomes – always with sustainability in mind. Based on science and advanced research capabilities, our aim is to deliver products and services for the entire reproductive-health journey, providing consistent performance and guaranteed quality. Currently, we are approximately 1,100 people worldwide headquartered in Gothenburg, Sweden. Our products and services are available in more than 125 countries, through our own presence in more than 25 countries and a vast network of distributors for the rest of the world. We are on a mission to be the leading valued solution provider in reproductive health and to support customers with successful treatment outcomes.
- Webbplats
-
https://www.vitrolife.com
Extern länk för Vitrolife, Part of Vitrolife Group
- Bransch
- Forskning inom bioteknik
- Företagsstorlek
- 1 001–5 000 anställda
- Huvudkontor
- Västra Frölunda
- Typ
- Publikt aktiebolag
- Grundat
- 1994
Adresser
Anställda på Vitrolife, Part of Vitrolife Group
-
Neven Zoric
Vice President, Commercial Excellence på Vitrolife Group
-
Eva Salenius-Lundberg
LEAN professional, Project Manager, Mechanical and Biomedical Engineer
-
Luis Aznar
Sales & Marketing Director Southwestern Europe, Africa & Israel - Vitrolife Group
-
Per Isaksson
Controller at Vitrolife
Uppdateringar
-
Sense the difference – Precision and comfort in every retrieval A successful oocyte retrieval needs to be fast, precise, and retrieve the maximum number of undamaged oocytes without complications. It is a critical procedure, involving a lot of anxiety for the patient, and requires gentle handling from many perspectives. One way to support a successful outcome is to use a needle that enables a fast and precise procedure. This will minimise stress and ensure that the maximum number of intact oocytes can be retrieved. Our unique Sense™ needle comes with several benefits for both you and your patients. Learn more here: https://ow.ly/4UqY50TpVS1 #VitrolifeGroup #Vitrolife #Igenomix #IVF #VitrolifeAcademy #reproductiveassistance #fertilitytreatment #oocyteretrieval #Sense
-
First #VitroGreen meeting with our UK partner clinics! Last week, we were delighted to meet several green ambassadors from partner clinics across the UK to discuss all things sustainability in the IVF lab and the launch of a new pilot recycling programme. We realised that we are only at the beginning of the sustainability journey in our industry, but we are all equally eager to scale our efforts for the benefit of future generations. A big thank you for your commitment: cath Drezet, Care Fertility Allison Benn, Care Fertility Lucy Frost, RKB Fran Farlie, Concept Fertility Sylwia Milne, NHS Grampian Inés Chapa-Chordá, Cambridge University Hospitals NHS Foundation trust Sonya Davey, Kate Gresty, Sabrina Ritossa Fernandez, Tania Sande Beiro from Vitrolife Group You are making a difference!💚 Stay tuned for our #Vitrogreen journey as we extend it to other countries! #VitrolifeGroup #Vitrolife #Igenomix #Vitrogreen
-
We are happy to announce that Vitrolife Group will be attending the #ASRM2024 Scientific Congress & Expo, held in beautiful Denver, Colorado, USA, from October 19th to 23rd, 2024. This year, we have a lot of exciting news to share, and we look forward to meeting you at our booth (153) at the congress to showcase everything we've prepared for you. Stay tuned to learn more about what Vitrolife & Igenomix, both part of the #VitrolifeGroup, will be doing at ASRM 2024. See you in Denver! #VitrolifeGroup #Vitrolife #Igenomix #ASRM2024 #IVF #IVFCongress #reproductiveassistance #fertilitytreatment
-
Join our upcoming webinar where Dr. Kelly Tilleman, IVF Laboratory Director at UZ Gent, Belgium, will present on “Safety of your gametes and embryos with eWitness”. In this webinar, Dr. Tilleman will demonstrate the implementation and use of an electronic witnessing system in their IVF laboratory and explain how it helps ensure the safe tracking and identification of their patients' gametes and embryos throughout the IVF process. 📅 Date: October 3rd ⏰ Time: 13:00 (UTC) / 15:00 (CEST) 👉 Register here: https://ow.ly/I8KJ50Tu7qH If you register but can't attend the live session, we'll record it and send it to you afterwards. #VitrolifeGroup #Vitrolife #Igenomix #IVF #VitrolifeAcademy #eWitness #IVFclinic #IVFsuccess #Fertilitytreatment *eWitness is currently not available in all markets. For the US market, barcode labeling will be available later this fall and other labeling and tracking systems will be introduced in 2025.
-
"Culture media with antioxidants improved fertilization, preimplantation embryo development and clinical outcomes of advanced age patients." These are the findings in a recent study by Dr. Shigetoshi Mizumoto et al., published in Reproductive BioMedicine Online. The RCT demonstrated a higher live birth rate for women aged 35-40 compared with G-series media. Read more here: https://lnkd.in/dgT2cNEH Launched in 2018, Gx Media includes a unique triple antioxidant protection for improved embryo viability. The three antioxidants have been added to our gamete-handling media (Gx-MOPS PLUS™), IVF media (Gx-IVF™), and culture media (Gx-TL™) to form a protective barrier against oxidative stress, ensuring your embryos remain safe and sound throughout the entire IVF cycle. To learn more about Gx Media, visit: https://lnkd.in/dKBfZGFx We would also like to recommend our recorded webinar, “30 Years of Media Development in the Battle Against Oxidative Stress – The Importance of Antioxidants for Improved Embryo Viability.” In this webinar, experts in the field of IVF with extensive experience using antioxidants in their culture media will discuss the subject: https://lnkd.in/dRVsJcDZ #VitrolifeGroup #Vitrolife #Igenomix #IVF #Togetheralltheway #VitrolifeAcademy #fertilitytreatment #ivfclinic #ivfsuccess #reproductivemedicine
-
Vitrolife achieves ISO 14001 environmental certification with top marks! We are proud to announce that the Vitrolife Group headquarters in Gothenburg, where a significant part of our production is based, has successfully passed the ISO 14001 audit with flying colours! After a thorough 1.5-day assessment of our environmental management system by the notified body, we achieved certification with zero non-conformities, recognising our dedication to environmental excellence. This milestone is a testament to the dedication and hard work of our entire team. Every colleague has played a vital role in nurturing a culture of sustainability and environmental responsibility, making this achievement possible. A heartfelt thank you to everyone involved—your efforts are truly making a difference. We look forward to continuing our sustainability journey together as we strive to create a better future for the next generation and beyond🍀
-
Vitrolife, Part of Vitrolife Group omdelade detta
📢 Vitrolife Group Celebrated the Opening of a New Laboratory in Miami!🎉 We are thrilled to announce the launch of Vitrolife Group's newest state-of-the-art facility in Miami! On September 17, we celebrated this significant milestone with an Open House event, where we welcomed our employees, customers, and partners to tour the laboratory and witness firsthand the cutting-edge innovations we have in our new lab. This new Igenomix Genetic Testing Laboratory, Part of Vitrolife Group, represents a major leap forward for Vitrolife Group, providing the capacity to implement advanced technology and drive innovation thanks to our highly skilled technical team and the introduction of groundbreaking equipment. We look forward to continuing to deliver excellence reproductive health from our new Miami location! #VitrolifeGroup #Vitrolife #Igenomix #ExcellenceinReproductiveHealth
-
Join our upcoming webinar where Dr. Kelly Tilleman, IVF Laboratory Director at UZ Gent, Belgium, will present on “Safety of your gametes and embryos with eWitness”. In this webinar, Dr. Tilleman will demonstrate the implementation and use of an electronic witnessing system in their IVF laboratory and explain how it helps ensure the safe tracking and identification of their patients' gametes and embryos throughout the IVF process. 📅 Date: October 3rd ⏰ Time: 13:00 (UTC) / 15:00 (CEST) 👉 Register here: https://ow.ly/I8KJ50Tu7qH eWitness* is the latest addition to our portfolio of medical devices. This advanced electronic witnessing system for IVF treatments plays a critical role in managing the quality of IVF treatment programmes. It helps prevent errors such as the mix-up of sperm, eggs, and embryos, while providing clear, actionable insights at every step of the process. To learn more about eWitness, visit: https://ow.ly/MZ3a50Tu7qI #VitrolifeGroup #Vitrolife #Igenomix #IVF #VitrolifeAcademy #eWitness #IVFclinic #IVFsuccess #Fertilitytreatment *eWitness is currently not available in all markets.
-
Ricardo Capella is the Vitrolife Group’s Senior VP of Genetics. For him, quality is one of the most critical factors in delivering our value proposition. In this video, he explains why one of Vitrolife Group's core values, 'Quality,' plays an extremely important role in interactions with customers. Discover our values through the voices of those within the Vitrolife Group: https://ow.ly/mciU50TqCJI #VitrolifeGroup #Vitrolife #Igenomix #DecadesOfInnovation #ValuesOfVitrolifeGroup #reproductivehealth